[Betamethasone dipropionate and iodochloroxyquinoline in the therapy of secondarily infected steroid-sensitive skin diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007464:Clioquinol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D008875:Middle Aged; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D006912:Hydroxyquinolines; D007464:Clioquinol; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone
L'associazione betametasone dipropionato e iodoclorossichinolina nella terapia delle forme cutanee steroidosensibili secondariamente infette.